Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
A Randomized Pilot Trial of Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this study is to compare the efficacy of PVI irrigation to no irrigation for decreasing postoperative intra-abdominal abscesses in children with perforated appendicitis. Additionally, this study aims to verify the safety profile of dilute PVI for intra-abdominal irrigation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2015
CompletedFirst Posted
Study publicly available on registry
January 26, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedResults Posted
Study results publicly available
April 17, 2019
CompletedApril 17, 2019
March 1, 2019
1.9 years
December 21, 2015
March 6, 2019
March 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Postoperative Intra-abdominal Abscess
30 days postoperative intra-abdominal abscess was confirmed by an image using a standardized definition and protocol
30 days post surgery
Secondary Outcomes (3)
Total Hospital Length of Stay
30 days post surgery
Number of Participants Who Were Readmitted to the Hospital
30 days post surgery
Number of Participants Who Visited the Emergency Room
30 days post surgery
Study Arms (2)
Povidone-iodine irrigation
EXPERIMENTALNo irrigation
ACTIVE COMPARATORInterventions
Povidone-iodine (PVI) is an antiseptic solution consisting of polyvinylpyrrolidone with water, iodide, and 1% available iodine. It has bactericidal ability against a large array of pathogens, including those pathogens which commonly cause postoperative IAA in children with perforated appendicitis. 1% PVI will be used. Once the appendix has been removed and hemostasis ensured, the surgeon will perform the irrigation with 10cc/kg (minimum 100ml and maximum 1000ml) of 1% PVI. After completing the irrigation, the surgeon will suction out all intra-abdominal fluid into a suction canister.
Patients allocated to the control group will not undergo intra-abdominal irrigation.
Eligibility Criteria
You may qualify if:
- Children who undergo an appendectomy for perforated appendicitis. (Appendicitis: Diagnosis is made intraoperatively by the surgeon. Diagnosis Method: The visualization of a gross defect in the appendiceal wall or the presence of intraperitoneal stool or a fecalith at the time of operation.)
You may not qualify if:
- Patients presenting with simple or gangrenous appendicitis
- Patients with a history of iodine sensitivity, thyroid disease or renal disease
- Patients undergoing interval or incidental appendectomy
- Patients/parents/legal guardians who are both non-English and non-Spanish speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Related Publications (1)
Anderson KT, Putnam LR, Bartz-Kurycki MA, Hamilton EC, Yafi M, Pedroza C, Austin MT, Kawaguchi AL, Kao LS, Lally KP, Tsao K. Povidone-iodine Irrigation for Pediatric Perforated Appendicitis May Be Protective: A Bayesian Pilot Randomized Controlled Trial. Ann Surg. 2020 May;271(5):827-833. doi: 10.1097/SLA.0000000000003398.
PMID: 31567357DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kuojen Tsao
- Organization
- McGovern Medical School, University of Texas Health Sciences Center at Houston
Study Officials
- PRINCIPAL INVESTIGATOR
KuoJen Tsao, MD
The University of Texas Health Science Center, Houston
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 21, 2015
First Posted
January 26, 2016
Study Start
April 1, 2016
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
April 17, 2019
Results First Posted
April 17, 2019
Record last verified: 2019-03